{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:14:45Z","timestamp":1790864085196,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"crossref","award":["20194Y0477"],"award-info":[{"award-number":["20194Y0477"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Fund for Clinical Medical Research of Shanghai Municipal Health Commission","award":["202040127"],"award-info":[{"award-number":["202040127"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progestins can suppress endogenous luteinising hormone (LH) secretion from the pituitary gland and have shown similar efficacy in terms of collecting competent oocytes and embryos; however, some inconsistencies have been proposed regarding the quality of embryos collected with the use of progestins. This study aimed to evaluate euploidy rates and pregnancy outcomes in preimplantation genetic testing for aneuploidy (PGT-A) cycles using the progestin-primed ovarian stimulation (PPOS) protocol versus the gonadotropin-releasing hormone (GnRH) agonist\/antagonist protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study included 608 PGT-A cycles: 146 women in the PPOS group, 160 women in the GnRH agonist group, and 302 women in the GnRH antagonist group. This study was performed at the in vitro fertilisation (IVF) centre of Shanghai First Maternity and Infant Hospital between January 2019 and December 2021. Additionally, 267 corresponding first frozen embryo transfer (FET) cycles were analysed to assess pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The euploid blastocyst rate per injected metaphase II(MII) oocytes (14.60% vs. 14.09% vs. 13.94%) was comparable among the three groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). No significant differences were observed among the three groups regarding pregnancy outcomes, including biochemical pregnancy, clinical pregnancy, ongoing pregnancy, implantation, miscarriage, ectopic pregnancy, and live birth rates per transfer in the first FET cycles (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The PPOS protocol had no negative effect on euploid blastocyst formation, and the pregnancy outcomes in FET cycles using the PPOS protocol were similar to those of the GnRH agonist and antagonist protocols.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      This trial was retrospectively registered\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-023-01000-1","type":"journal-article","created":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T23:07:51Z","timestamp":1673824071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist\/antagonist protocol"],"prefix":"10.1186","volume":"28","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"1000_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fmed.2019.00197","volume":"6","author":"P Pirtea","year":"2019","unstructured":"Pirtea P, de Ziegler D, Poulain M, Ayoubi JM. New twists in ovarian stimulation and their practical implications. Front Med. 2019;6:197.","journal-title":"Front Med"},{"key":"1000_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bpobgyn.2006.08.002","volume":"21","author":"BC Tarlatzis","year":"2007","unstructured":"Tarlatzis BC, Kolibianakis EM. GnRH agonists vs antagonists. Best Pract Res Clin Obstet Gynaecol. 2007;21:57\u201365.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"62\u201370","key":"1000_CR3","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, Ai A, Shoham Z. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(62\u201370): e63.","journal-title":"Fertil Steril"},{"key":"1000_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.rbmo.2018.07.006","volume":"37","author":"G Sighinolfi","year":"2018","unstructured":"Sighinolfi G, Sunkara SK, La Marca A. New strategies of ovarian stimulation based on the concept of ovarian follicular waves: from conventional to random and double stimulation. Reprod Biomed Online. 2018;37:489\u201397.","journal-title":"Reprod Biomed Online"},{"key":"1000_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00404-018-4856-8","volume":"298","author":"N Iwami","year":"2018","unstructured":"Iwami N, Kawamata M, Ozawa N, Yamamoto T, Watanabe E, Moriwaka O, Kamiya H. New trial of progestin-primed ovarian stimulation using dydrogesterone versus a typical GnRH antagonist regimen in assisted reproductive technology. Arch Gynecol Obstet. 2018;298:663\u201371.","journal-title":"Arch Gynecol Obstet"},{"key":"1000_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.705264","volume":"12","author":"M Du","year":"2021","unstructured":"Du M, Zhang J, Li Z, Liu X, Li J, Liu W, Guan Y. Comparison of the cumulative live birth rates of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols in patients with low prognosis. Front Endocrinol. 2021;12: 705264.","journal-title":"Front Endocrinol"},{"key":"1000_CR7","first-page":"671","volume":"17","author":"M Eftekhar","year":"2019","unstructured":"Eftekhar M, Hoseini M, Saeed L. Progesterone-primed ovarian stimulation in polycystic ovarian syndrome: an RCT. Int J Reprod Biomed. 2019;17:671\u20136.","journal-title":"Int J Reprod Biomed"},{"key":"1000_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/humrep\/deu033","volume":"29","author":"A Capalbo","year":"2014","unstructured":"Capalbo A, Rienzi L, Cimadomo D, Maggiulli R, Elliott T, Wright G, Nagy ZP, Ubaldi FM. Correlation between standard blastocyst morphology, euploidy and implantation: an observational study in two centers involving 956 screened blastocysts. Hum Reprod. 2014;29:1173\u201381.","journal-title":"Hum Reprod"},{"key":"1000_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ogc.2017.10.009","volume":"45","author":"C Sullivan-Pyke","year":"2018","unstructured":"Sullivan-Pyke C, Dokras A. Preimplantation genetic screening and preimplantation genetic diagnosis. Obstet Gynecol Clin North Am. 2018;45:113\u201325.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1000_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrg3245","volume":"13","author":"SI Nagaoka","year":"2012","unstructured":"Nagaoka SI, Hassold TJ, Hunt PA. Human aneuploidy: mechanisms and new insights into an age-old problem. Nat Rev Genet. 2012;13:493\u2013504.","journal-title":"Nat Rev Genet"},{"key":"1000_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humrep\/del316","volume":"22","author":"A Sato","year":"2007","unstructured":"Sato A, Otsu E, Negishi H, Utsunomiya T, Arima T. Aberrant DNA methylation of imprinted loci in superovulated oocytes. Hum Reprod. 2007;22:26\u201335.","journal-title":"Hum Reprod"},{"key":"1000_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","volume":"101","author":"RG Steward","year":"2014","unstructured":"Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, Muasher SJ. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967\u201373.","journal-title":"Fertil Steril"},{"key":"1000_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/humrep\/del484","volume":"22","author":"EB Baart","year":"2007","unstructured":"Baart EB, Martini E, Eijkemans MJ, Van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod. 2007;22:980\u20138.","journal-title":"Hum Reprod"},{"key":"1000_CR14","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s10815-021-02197-y","volume":"38","author":"ML Pardinas","year":"2021","unstructured":"Pardinas ML, Nohales M, Labarta E, De Los Santos JM, Mercader A, Remohi J, Bosch E, De Los Santos MJ. Elevated serum progesterone does not impact euploidy rates in PGT-A patients. J Assist Reprod Genet. 2021;38:1819\u201326.","journal-title":"J Assist Reprod Genet"},{"key":"1000_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","volume":"109","author":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted","year":"2018","unstructured":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted. Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril. 2018;109:429\u201336.","journal-title":"Fertil Steril"},{"key":"1000_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"DK Gardner","year":"2000","unstructured":"Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73:1155\u20138.","journal-title":"Fertil Steril"},{"key":"1000_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ijgo.13933","volume":"157","author":"W Li","year":"2022","unstructured":"Li W, Zhang W, Zhao H, Chu Y, Liu X. Efficacy of the depot gonadotropin-releasing hormone agonist protocol on in vitro fertilization outcomes in young poor ovarian responders from POSEIDON group 3. Int J Gynaecol Obstet. 2022;157:733\u201340.","journal-title":"Int J Gynaecol Obstet"},{"key":"1000_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000909","volume":"94","author":"X Zhu","year":"2015","unstructured":"Zhu X, Zhang X, Fu Y. Utrogestan as an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Medicine. 2015;94: e909.","journal-title":"Medicine"},{"key":"1000_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002939","volume":"95","author":"Y Wang","year":"2016","unstructured":"Wang Y, Chen Q, Wang N, Chen H, Lyu Q, Kuang Y. Controlled ovarian stimulation using medroxyprogesterone acetate and hMG in patients with polycystic ovary syndrome treated for IVF: a double-blind randomized crossover clinical trial. Medicine. 2016;95: e2939.","journal-title":"Medicine"},{"key":"1000_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004193","volume":"95","author":"X Zhu","year":"2016","unstructured":"Zhu X, Ye H, Fu Y. The utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF\/ICSI treatments. Medicine. 2016;95: e4193.","journal-title":"Medicine"},{"key":"1000_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.fertnstert.2016.10.030","volume":"107","author":"X Zhu","year":"2017","unstructured":"Zhu X, Ye H, Fu Y. Use of utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a \u201cfreeze all\u201d strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg. Fertil Steril. 2017;107:379-386.e374.","journal-title":"Fertil Steril"},{"key":"1000_CR22","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/humrep\/deaa068","volume":"35","author":"A La Marca","year":"2020","unstructured":"La Marca A, Capuzzo M, Sacchi S, Imbrogno MG, Spinella F, Varricchio MT, Minasi MG, Greco P, Fiorentino F, Greco E. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation. Hum Reprod. 2020;35:1325\u201331.","journal-title":"Hum Reprod"},{"key":"1000_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/GCO.0000000000000362","volume":"29","author":"B Ata","year":"2017","unstructured":"Ata B, Seli E. A universal freeze all strategy: why it is not warranted. Curr Opin Obstet Gynecol. 2017;29:136\u201345.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1000_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","volume":"27","author":"B Ata","year":"2021","unstructured":"Ata B, Capuzzo M, Turkgeldi E, Yildiz S, La Marca A. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses. Hum Reprod Update. 2021;27:48\u201366.","journal-title":"Hum Reprod Update"},{"key":"1000_CR25","first-page":"211","volume":"23","author":"N Massin","year":"2017","unstructured":"Massin N. New stimulation regimens: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017;23:211\u201320.","journal-title":"Hum Reprod Update"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01000-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,15]],"date-time":"2023-01-15T23:09:10Z","timestamp":1673824150000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1000"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01000-1","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Shanghai First Maternity and Infant Hospital (KS20163).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}